vs
Amalgamated Financial Corp.(AMAL)与IRONWOOD PHARMACEUTICALS INC(IRWD)财务数据对比。点击上方公司名可切换其他公司
Amalgamated Financial Corp.的季度营收约是IRONWOOD PHARMACEUTICALS INC的1.8倍($85.2M vs $47.7M),Amalgamated Financial Corp.同比增速更快(9.4% vs -47.3%),Amalgamated Financial Corp.自由现金流更多($134.4M vs $74.6M),过去两年Amalgamated Financial Corp.的营收复合增速更高(4.3% vs -20.2%)
CI金融集团是一家总部位于加拿大安大略省多伦多的投资管理公司,面向高净值个人投资者提供投资管理与财富管理服务,同时也为投资组合经理及机构投资者提供经纪与交易服务。
Ironwood制药公司是一家上市制药企业,其前身为Microbia公司,专注于制药领域相关业务研发与运营,面向市场开发各类创新医药产品,满足未被充分满足的临床医疗需求。
AMAL vs IRWD — 直观对比
营收规模更大
AMAL
是对方的1.8倍
$47.7M
营收增速更快
AMAL
高出56.7%
-47.3%
自由现金流更多
AMAL
多$59.8M
$74.6M
两年增速更快
AMAL
近两年复合增速
-20.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $85.2M | $47.7M |
| 净利润 | — | $-2.3M |
| 毛利率 | — | — |
| 营业利润率 | 39.0% | 14.3% |
| 净利率 | — | -4.8% |
| 营收同比 | 9.4% | -47.3% |
| 净利润同比 | — | -200.9% |
| 每股收益(稀释后) | $0.88 | $0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
AMAL
IRWD
| Q4 25 | $85.2M | $47.7M | ||
| Q3 25 | $85.6M | $122.1M | ||
| Q2 25 | $80.9M | $85.2M | ||
| Q1 25 | $77.0M | $41.1M | ||
| Q4 24 | $77.9M | $90.5M | ||
| Q3 24 | $81.0M | $91.6M | ||
| Q2 24 | $78.5M | $94.4M | ||
| Q1 24 | $78.3M | $74.9M |
净利润
AMAL
IRWD
| Q4 25 | — | $-2.3M | ||
| Q3 25 | $26.8M | $40.1M | ||
| Q2 25 | $26.0M | $23.6M | ||
| Q1 25 | $25.0M | $-37.4M | ||
| Q4 24 | — | $2.3M | ||
| Q3 24 | $27.9M | $3.6M | ||
| Q2 24 | $26.8M | $-860.0K | ||
| Q1 24 | $27.2M | $-4.2M |
营业利润率
AMAL
IRWD
| Q4 25 | 39.0% | 14.3% | ||
| Q3 25 | 42.9% | 61.8% | ||
| Q2 25 | 43.8% | 53.2% | ||
| Q1 25 | 45.1% | -70.7% | ||
| Q4 24 | 42.4% | 34.8% | ||
| Q3 24 | 47.2% | 28.0% | ||
| Q2 24 | 45.6% | 26.5% | ||
| Q1 24 | 49.2% | 14.7% |
净利率
AMAL
IRWD
| Q4 25 | — | -4.8% | ||
| Q3 25 | 31.3% | 32.8% | ||
| Q2 25 | 32.1% | 27.7% | ||
| Q1 25 | 32.5% | -90.9% | ||
| Q4 24 | — | 2.5% | ||
| Q3 24 | 34.5% | 4.0% | ||
| Q2 24 | 34.1% | -0.9% | ||
| Q1 24 | 34.8% | -5.6% |
每股收益(稀释后)
AMAL
IRWD
| Q4 25 | $0.88 | $0.01 | ||
| Q3 25 | $0.88 | $0.23 | ||
| Q2 25 | $0.84 | $0.14 | ||
| Q1 25 | $0.81 | $-0.23 | ||
| Q4 24 | $0.78 | $0.03 | ||
| Q3 24 | $0.90 | $0.02 | ||
| Q2 24 | $0.87 | $-0.01 | ||
| Q1 24 | $0.89 | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $291.2M | $215.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $794.5M | $-261.8M |
| 总资产 | $8.9B | $396.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
AMAL
IRWD
| Q4 25 | $291.2M | $215.5M | ||
| Q3 25 | $115.5M | $140.4M | ||
| Q2 25 | $171.1M | $92.9M | ||
| Q1 25 | $65.7M | $108.5M | ||
| Q4 24 | $60.7M | $88.6M | ||
| Q3 24 | $149.2M | $88.2M | ||
| Q2 24 | $58.0M | $105.5M | ||
| Q1 24 | $155.2M | $121.5M |
总债务
AMAL
IRWD
| Q4 25 | — | — | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | — | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M | ||
| Q1 24 | — | $398.3M |
股东权益
AMAL
IRWD
| Q4 25 | $794.5M | $-261.8M | ||
| Q3 25 | $775.6M | $-264.2M | ||
| Q2 25 | $754.0M | $-308.2M | ||
| Q1 25 | $736.0M | $-334.1M | ||
| Q4 24 | $707.7M | $-301.3M | ||
| Q3 24 | $698.2M | $-311.3M | ||
| Q2 24 | $646.0M | $-321.7M | ||
| Q1 24 | $616.8M | $-330.5M |
总资产
AMAL
IRWD
| Q4 25 | $8.9B | $396.9M | ||
| Q3 25 | $8.7B | $396.1M | ||
| Q2 25 | $8.6B | $342.9M | ||
| Q1 25 | $8.3B | $327.2M | ||
| Q4 24 | $8.3B | $350.9M | ||
| Q3 24 | $8.4B | $389.5M | ||
| Q2 24 | $8.3B | $395.6M | ||
| Q1 24 | $8.1B | $438.8M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $135.8M | $74.6M |
| 自由现金流经营现金流 - 资本支出 | $134.4M | $74.6M |
| 自由现金流率自由现金流/营收 | 157.8% | 156.3% |
| 资本支出强度资本支出/营收 | 1.6% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $229.4M | $127.0M |
8季度趋势,按日历期对齐
经营现金流
AMAL
IRWD
| Q4 25 | $135.8M | $74.6M | ||
| Q3 25 | $39.5M | $47.6M | ||
| Q2 25 | $24.9M | $-15.1M | ||
| Q1 25 | $34.2M | $20.0M | ||
| Q4 24 | $124.1M | $15.2M | ||
| Q3 24 | $35.8M | $9.9M | ||
| Q2 24 | $28.0M | $33.5M | ||
| Q1 24 | $31.3M | $45.0M |
自由现金流
AMAL
IRWD
| Q4 25 | $134.4M | $74.6M | ||
| Q3 25 | $38.3M | $47.6M | ||
| Q2 25 | $24.2M | $-15.1M | ||
| Q1 25 | $32.5M | $19.9M | ||
| Q4 24 | $122.3M | — | ||
| Q3 24 | $35.2M | $9.9M | ||
| Q2 24 | $27.8M | $33.4M | ||
| Q1 24 | $31.1M | $44.9M |
自由现金流率
AMAL
IRWD
| Q4 25 | 157.8% | 156.3% | ||
| Q3 25 | 44.7% | 39.0% | ||
| Q2 25 | 29.9% | -17.7% | ||
| Q1 25 | 42.2% | 48.4% | ||
| Q4 24 | 157.0% | — | ||
| Q3 24 | 43.4% | 10.8% | ||
| Q2 24 | 35.4% | 35.4% | ||
| Q1 24 | 39.7% | 60.0% |
资本支出强度
AMAL
IRWD
| Q4 25 | 1.6% | 0.0% | ||
| Q3 25 | 1.4% | 0.0% | ||
| Q2 25 | 0.9% | 0.0% | ||
| Q1 25 | 2.3% | 0.1% | ||
| Q4 24 | 2.3% | 0.0% | ||
| Q3 24 | 0.7% | 0.0% | ||
| Q2 24 | 0.3% | 0.1% | ||
| Q1 24 | 0.3% | 0.1% |
现金转化率
AMAL
IRWD
| Q4 25 | — | — | ||
| Q3 25 | 1.47× | 1.19× | ||
| Q2 25 | 0.96× | -0.64× | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | — | 6.74× | ||
| Q3 24 | 1.28× | 2.71× | ||
| Q2 24 | 1.05× | — | ||
| Q1 24 | 1.15× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图